1. Home
  2. EOLS vs TEN Comparison

EOLS vs TEN Comparison

Compare EOLS & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • TEN
  • Stock Information
  • Founded
  • EOLS 2012
  • TEN 1993
  • Country
  • EOLS United States
  • TEN Greece
  • Employees
  • EOLS N/A
  • TEN N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • TEN
  • Sector
  • EOLS Health Care
  • TEN
  • Exchange
  • EOLS Nasdaq
  • TEN NYSE
  • Market Cap
  • EOLS 589.3M
  • TEN 620.9M
  • IPO Year
  • EOLS 2018
  • TEN N/A
  • Fundamental
  • Price
  • EOLS $9.53
  • TEN $19.40
  • Analyst Decision
  • EOLS Strong Buy
  • TEN Buy
  • Analyst Count
  • EOLS 5
  • TEN 2
  • Target Price
  • EOLS $23.75
  • TEN $30.50
  • AVG Volume (30 Days)
  • EOLS 889.3K
  • TEN 309.0K
  • Earning Date
  • EOLS 08-05-2025
  • TEN 09-10-2025
  • Dividend Yield
  • EOLS N/A
  • TEN 7.73%
  • EPS Growth
  • EOLS N/A
  • TEN N/A
  • EPS
  • EOLS N/A
  • TEN 4.46
  • Revenue
  • EOLS $275,463,000.00
  • TEN $799,523,000.00
  • Revenue This Year
  • EOLS $33.42
  • TEN N/A
  • Revenue Next Year
  • EOLS $33.18
  • TEN $8.89
  • P/E Ratio
  • EOLS N/A
  • TEN $4.35
  • Revenue Growth
  • EOLS 25.38
  • TEN N/A
  • 52 Week Low
  • EOLS $8.67
  • TEN $13.40
  • 52 Week High
  • EOLS $17.82
  • TEN $26.90
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 51.00
  • TEN 49.11
  • Support Level
  • EOLS $9.12
  • TEN $18.82
  • Resistance Level
  • EOLS $10.20
  • TEN $20.28
  • Average True Range (ATR)
  • EOLS 0.40
  • TEN 0.53
  • MACD
  • EOLS 0.05
  • TEN -0.09
  • Stochastic Oscillator
  • EOLS 44.17
  • TEN 27.10

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About TEN TSAKOS ENERGY NAVIGATION

Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.

Share on Social Networks: